Entrada Therapeutics, Inc. (TRDA)
6.84
-0.01
(-0.15%)
USD |
NASDAQ |
May 08, 16:00
6.76
-0.08
(-1.17%)
After-Hours: 20:00
Entrada Therapeutics Total Liabilities (Quarterly) : 64.66M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 7.122B |
| Tyra Biosciences, Inc. | 24.87M |
| Biogen, Inc. | 10.83B |
| Catalyst Pharmaceuticals, Inc. | 152.54M |
| XOMA Royalty Corp. | 168.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 335.52M |
| Shareholders Equity (Quarterly) | 270.85M |
| Debt to Equity Ratio | 0.1837 |
| Current Ratio | 13.90 |
| Net Debt Paydown Yield | 0.39% |